Home › Funds › PFM Health Sciences, LP › DHR
PFM Health Sciences, LP position in DHR
DANAHER CORP DEL · Industrials
PFM Health Sciences, LP reported holding 45,663 shares of DHR (DANAHER CORP DEL) in its Q3 2026 13F filing — a position valued at US$10.1M, representing 1.03% of its reported portfolio and ranking #39 among its reported holdings. PFM Health Sciences, LP has disclosed DHR holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's DHR position evolved
PFM Health Sciences, LP first disclosed a stake in DHR in Q3 2023 at 175,690 shares (US$43.6M). Across 9 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 45,663 shares valued at US$10.1M. Notable position changes include a 29% trim in Q4 2023 (shares rose 8% over the following quarter), a 44% increase in Q2 2025 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 175.69K | $43.59M | New |
| Q4 2023 | 125.52K | $29.04M | Reduce |
| Q1 2024 | 125.52K | $31.34M | Hold |
| Q2 2024 | 125.52K | $31.36M | Hold |
| Q3 2024 | 125.52K | $34.90M | Hold |
| Q4 2024 | 125.52K | $28.81M | Hold |
| Q1 2025 | 112.47K | $23.06M | Reduce |
| Q2 2025 | 161.41K | $31.89M | Add |
| Q3 2026 | 45.66K | $10.12M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DHR and 13F data
DHR (DANAHER CORP DEL) is a Industrials company. 23 other funds we track also report a position in DHR — the largest reported positions include Fidelity Management & Research (FMR) (US$8.58B), Capital International Investors (US$4.02B), Capital Research Global Investors (US$3.54B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DHR
- Fidelity Management & Research (FMR) 38.71M sh · $8.58B · Q3 2026
- Capital International Investors 18.15M sh · $4.02B · Q3 2026
- Capital Research Global Investors 16.00M sh · $3.54B · Q3 2026
- Wellington Management Group 16.32M sh · $3.11B · Q2 2026
- DODGE & COX 10.08M sh · $2.23B · Q3 2026
- EAGLE CAPITAL MANAGEMENT LLC 9.36M sh · $1.78B · Q2 2026
- Jupiter Topco LLC 7.65M sh · $1.46B · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.92M sh · $1.32B · Q2 2026
- Janus Henderson Group 6.49M sh · $1.22B · Q1 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held DHR?
PFM Health Sciences, LP has disclosed DHR holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
What is PFM Health Sciences, LP's current position in DHR?
As of Q3 2026, PFM Health Sciences, LP holds 45.66K shares of DHR (DANAHER CORP DEL), valued at $10.12M, representing 1.03% of its reported portfolio and ranking #39.
Has PFM Health Sciences, LP been buying or selling DHR?
In the latest 13F filing (Q3 2026), PFM Health Sciences, LP newly opened its position in DHR.
Which other funds hold DHR?
Other major institutional holders of DHR include Fidelity Management & Research (FMR), Capital International Investors, Capital Research Global Investors, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.